Retrospective review of immobilization vs. immediate resumption of activity in patients with Oligoarticular juvenile idiopathic arthritis following knee injections

Table 3 (Final/Follow-up) Clinical Characteristics, N = 167 (single injection)

N(%) or Median (25th–75th)
	All (N = 167)	CHOP (N = 72)	TSRH (N = 95)	P-value*	SMD
Joint swelling
> 1 (vs 0)	48 (29%)	15 (21%)	33 (35%)	0.0493	0.31
Joint tenderness
> 1 (vs 0)	9 (5%)	6 (8%)	3 (3%)	0.18	0.22
Joint limited range of motion
> 1 (vs 0)	33 (20%)	7 (10%)	26 (27%)	0.0046	0.47
Arthritis reoccurrence – Yes	55 (33%)	19 (26%)	36 (38%)	0.14	0.25
If yes, number of months until arthritis reoccurred	10 (4–19)	10 (4–19)	10.5 (4–18)	0.87	0.05
CHAQ Score Follow-up^a	0.125 (0–0.50)	0.125 (0–0.125)	0.125 (0–0.50)	0.26	0.20
MD Global Score Follow-up^b	0 (0–1)	0 (0–1)	0 (0–1)	0.88	0.03
Pain Assessment Follow-up (1–10)	0 (0–3)	0 (0–3.5)	1(0–3)	0.90	0.02

*Wilcoxon Rank-Sum tests or Chi-squared/Fisher’s Exact Tests between CHOP and TSRH sites, alpha = 0.05
^aCHAQ missing, n = 34
^bMD Global missing, n = 30
^cPain assessment missing, n = 36
SMD: standardized mean difference. SMD > 0.25 (25%) indicates an imbalance between groups, P < 0.05 is considered statistically significant (shown in bold)

ISSN: 1546-0096